Advanced search
Publication Cover
Critical Reviews in Toxicology Volume 27, 1997 - Issue 4
Submit an article Journal homepage
73
Views
66
CrossRef citations to date
0
Altmetric
Research Article

The Molecular Epidemiology of Lung Cancer

Simon D. Spivack Laboratory of Human Toxicology and Molecular Epidemiology, Wadsworth Center, New York State Department of Health, Empire State Plaza, P.O. Box 509, Albany, NY, 12201-0509; Pulmonary and Critical Care Medicine, Albany Medical College, A-91, 47 New Scotland Avenue, Albany, NY, 12208
,
Michael J. Fasco Laboratory of Human Toxicology and Molecular Epidemiology, Wadsworth Center, New York State Department of Health, Empire State Plaza, P.O. Box 509, Albany, NY, 12201-0509
,
Vernon E. Walker Laboratory of Human Toxicology and Molecular Epidemiology, Wadsworth Center, New York State Department of Health, Empire State Plaza, P.O. Box 509, Albany, NY, 12201-0509
&
Laurence S. Kaminsky Laboratory of Human Toxicology and Molecular Epidemiology, Wadsworth Center, New York State Department of Health, Empire State Plaza, P.O. Box 509, Albany, NY, 12201-0509
Pages 319-365 | Published online: 25 Sep 2008

Citations (66)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Ya Wen Cheng & Huei Lee. (2003) Environmental Exposure and Lung Cancer Among Nonsmokers: An Example of Taiwanese Female Lung Cancer. Journal of Environmental Science and Health, Part C 21:1, pages 1-28.
Read now
Nico van Zandwijk & Ugo Pastorino. (2003) Chemoprevention of lung cancer: soon daily practice?. Expert Review of Anticancer Therapy 3:1, pages 91-98.
Read now

Articles from other publishers (64)

Zhenqiu Huang, Shixiang Sun, Moonsook Lee, Alexander Y. Maslov, Miao Shi, Spencer Waldman, Ava Marsh, Taha Siddiqui, Xiao Dong, Yakov Peter, Ali Sadoughi, Chirag Shah, Kenny Ye, Simon D. Spivack & Jan Vijg. (2022) Single-cell analysis of somatic mutations in human bronchial epithelial cells in relation to aging and smoking. Nature Genetics 54:4, pages 492-498.
Crossref
Matthew A. Brown, Zhixiu Li & Kim-Anh Lê Cao. (2020) Biomarker development for axial spondyloarthritis. Nature Reviews Rheumatology 16:8, pages 448-463.
Crossref
Prabhu Thirusangu & V. Vigneshwaran. 2020. Chronic Lung Diseases. Chronic Lung Diseases 129 141 .
Kwun M. Fong, Jill E. Larsen, Casey Wright, Krishna Sriram, Morgan Davidson, Marissa Daniels, Yoshitaka Sekido, Rayleen V. Bowman, Ian A. Yang & John D. Minna. 2017. The Molecular Basis of Human Cancer. The Molecular Basis of Human Cancer 447 496 .
Hyun-Ji Jang, Hye-Jin Boo, Ho Jin Lee, Hye-Young Min & Ho-Young Lee. (2016) Chronic Stress Facilitates Lung Tumorigenesis by Promoting Exocytosis of IGF2 in Lung Epithelial Cells. Cancer Research 76:22, pages 6607-6619.
Crossref
Kwun M. Fong, Marissa Daniels, Felicia Goh, Ian A. Yang & Rayleen V. Bowman. 2015. Lung Cancer. Lung Cancer 79 94 .
Joe E. Ensor. (2014) Biomarker Validation: Common Data Analysis Concerns. The Oncologist 19:8, pages 886-891.
Crossref
M. Kirsch-Volders, I. Decordier & D. Lison. (2013) Génotoxicité et exposition professionnelle ou environnementale. EMC - Pathologie professionnelle et de l 'environnement 8:1, pages 1-15.
Crossref
Andrew Rundle, Habibul Ahsan & Paolo Vineis. (2012) Better cancer biomarker discovery through better study design. European Journal of Clinical Investigation 42:12, pages 1350-1359.
Crossref
Huai-chih Chiang, Chin-Ying Wang, Hui-Ling Lee & Tsui-Chun Tsou. (2011) Metabolic effects of CYP2A6 and CYP2A13 on 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced gene mutation—A mammalian cell-based mutagenesis approach. Toxicology and Applied Pharmacology 253:2, pages 145-152.
Crossref
Bo Hang. (2010) Formation and Repair of Tobacco Carcinogen-Derived Bulky DNA Adducts. Journal of Nucleic Acids 2010, pages 1-29.
Crossref
Mark J. Hoenerhoff, Hue Hua Hong, Tai-vu Ton, Stephanie A. Lahousse & Robert C. Sills. (2009) A Review of the Molecular Mechanisms of Chemically Induced Neoplasia in Rat and Mouse Models in National Toxicology Program Bioassays and Their Relevance to Human Cancer. Toxicologic Pathology 37:7, pages 835-848.
Crossref
Fatma B'chir, Sofia Pavanello, Jalel Knani, Sami Boughattas, Maurice J. Arnaud & Saâd Saguem. (2009) CYP1A2 genetic polymorphisms and adenocarcinoma lung cancer risk in the Tunisian population. Life Sciences 84:21-22, pages 779-784.
Crossref
Jui-Pin Wu, Louis W. Chang, Hsien-Tsung Yao, Han Chang, Hui-Ti Tsai, Ming-Hsien Tsai, Teng-Kuang Yeh & Pinpin Lin. (2009) Involvement of Oxidative Stress and Activation of Aryl Hydrocarbon Receptor in Elevation of CYP1A1 Expression and Activity in Lung Cells and Tissues by Arsenic: An In Vitro and In Vivo Study. Toxicological Sciences 107:2, pages 385-393.
Crossref
Albert Rosenberger, Thomas Illig, Katrin Korb, Norman Klopp, Vera Zietemann, Gabi Wölke, Eckart Meese, Gerhard Sybrecht, Florian Kronenberg, Matthias Cebulla, Maria Degen, Peter Drings, Andreas Gröschel, Nikolaus Konietzko, Karsten grosse Kreymborg, Karl Häußinger, Gerd Höffken, Bettina Jilge, You-Dschun Ko, Harald Morr, Christine Schmidt, E-Wilhelm Schmidt, Dagmar Täuscher, Heike Bickeböller & H-Erich Wichmann. (2008) Do genetic factors protect for early onset lung cancer? A case control study before the age of 50 years. BMC Cancer 8:1.
Crossref
Simone G.J. van Breda, Theo M.C.M. de Kok & Joost H.M. van Delft. (2008) Mechanisms of colorectal and lung cancer prevention by vegetables: a genomic approach. The Journal of Nutritional Biochemistry 19:3, pages 139-157.
Crossref
Peter Gresner, Jolanta Gromadzinska & Wojciech Wasowicz. (2007) Polymorphism of selected enzymes involved in detoxification and biotransformation in relation to lung cancer. Lung Cancer 57:1, pages 1-25.
Crossref
Hugo E. Scaglia & Carlos Chichizola. (2007) Disruptores endocrinos y función testicular. Revista Internacional de Andrología 5:2, pages 181-192.
Crossref
M.L. Cote, A.S. Wenzlaff, C.H. Bock, S.J. Land, S.K. Santer, D.R. Schwartz & A.G. Schwartz. (2007) Combinations of cytochrome P-450 genotypes and risk of early-onset lung cancer in Caucasians and African Americans: A population-based study. Lung Cancer 55:3, pages 255-262.
Crossref
Nobuko Wakamatsu, Theodora R. devereux, Hue-Hua L. Hong & Robert C. Sills. (2016) Overview of the Molecular Carcinogenesis of Mouse Lung Tumor Models of Human Lung Cancer. Toxicologic Pathology 35:1, pages 75-80.
Crossref
Jong-Rung TsaiInn-Wen ChongChung-Chi ChenShiu-Ru LinChau-Chyun SheuJhi-Jhu Hwang. (2006) Mitogen-Activated Protein Kinase Pathway Was Significantly Activated in Human Bronchial Epithelial Cells by Nicotine. DNA and Cell Biology 25:5, pages 312-322.
Crossref
Micheline Kirsch-Volders, Marlies De Boeck & Dominique Lison. (2006) Génotoxicité et activité professionnelle. EMC - Pathologie professionnelle et de l 'environnement 1:1, pages 1-9.
Crossref
Christine C. Maurer & Konstantinos N. Syrigos. 2006. Tumors of the Chest. Tumors of the Chest 23 39 .
Nico van Zandwijk. (2005) Chemoprevention in lung carcinogenesis – An overview. European Journal of Cancer 41:13, pages 1990-2002.
Crossref
Y T Jin, Y C Xu, R D Yang, C F Huang, C W Xu & X Z He. (2005) Familial aggregation of lung cancer in a high incidence area in China. British Journal of Cancer 92:7, pages 1321-1325.
Crossref
Shou-Lin Wang, Xiao-Yang He & Jun-Yan Hong. (2005) HUMAN CYTOCHROME P450 2S1: LACK OF ACTIVITY IN THE METABOLIC ACTIVATION OF SEVERAL CIGARETTE SMOKE CARCINOGENS AND IN THE METABOLISM OF NICOTINE. Drug Metabolism and Disposition 33:3, pages 336-340.
Crossref
Louise RyanWenzheng Huang, Sally W Thurston, Karl T Kelsey, John K Wiencke & David C Christiani. (2016) On the use of biomarkers for environmental health research. Statistical Methods in Medical Research 13:3, pages 207-225.
Crossref
Renato Sotto-Mayor. (2004) Tabaco e genética**Conferência Thomé Villar, Funchal, 13 de Novembro de 2003. Revista Portuguesa de Pneumologia 10:1, pages S67-S78.
Crossref
Wolfgang Hiddemann, Heinz Huber & Claus R. BartramR. Schulte-Hermann & W. Parzefall. 2004. Die Onkologie. Die Onkologie 193 240 .
Stephen S. Hecht. 2004. Cancer Chemoprevention. Cancer Chemoprevention 21 35 .
Stephen S. Hecht. (2003) Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nature Reviews Cancer 3:10, pages 733-744.
Crossref
Nico van Zandwijk & Fred R Hirsch. (2003) Chemoprevention of lung cancer: current status and future prospects. Lung Cancer 42:2, pages 71-79.
Crossref
Weiguo Han, Brian T. Pentecost & Simon D. Spivack. (2003) Functional evaluation of novel single nucleotide polymorphisms and haplotypes in the promoter regions of CYP1B1 and CYP1A1 genes . Molecular Carcinogenesis 37:3, pages 158-169.
Crossref
Xinxin DingLaurence S. Kaminsky. (2003) Human Extrahepatic Cytochromes P450: Function in Xenobiotic Metabolism and Tissue-Selective Chemical Toxicity in the Respiratory and Gastrointestinal Tracts. Annual Review of Pharmacology and Toxicology 43:1, pages 149-173.
Crossref
N. van Zandwijk. 2003. Management des Lungenkarzinoms. Management des Lungenkarzinoms 439 445 .
Michael J Thun, S Jane Henley & Eugenia E Calle. (2002) Tobacco use and cancer: an epidemiologic perspective for geneticists. Oncogene 21:48, pages 7307-7325.
Crossref
John DiGiovanni & Suryanarayana Vulimiri. 2002. Biomarkers of Environmentally Associated Disease. Biomarkers of Environmentally Associated Disease.
Stephen S. Hecht. (2002) Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer. Carcinogenesis 23:6, pages 907-922.
Crossref
Nico van Zandwijk & Fred R. Hirsch. (2002) Chemoprevention strategies for non-small cell lung cancer. Current Opinion in Oncology 14:2, pages 185-190.
Crossref
Kwun M Fong & John D Minna. (2002) Molecular biology of lung cancer: Clinical implications. Clinics in Chest Medicine 23:1, pages 83-101.
Crossref
David O Carpenter, Kathleen Arcaro & David C Spink. (2002) Understanding the human health effects of chemical mixtures.. Environmental Health Perspectives 110:suppl 1, pages 25-42.
Crossref
Kwun M. Fong, Yoshitaka Sekido & John D. Minna. 2002. The Molecular Basis of Human Cancer. The Molecular Basis of Human Cancer 379 405 .
Nico van Zandwijk. (2001) Chemoprevention of lung cancer. Lung Cancer 34, pages 91-94.
Crossref
Eva Forgacs, Sabine Zöchbauer-Müller, Edit Oláh & John D. Minna. (2001) Molecular genetic abnormalities in the pathogenesis of human lung cancer. Pathology & Oncology Research 7:1, pages 6-13.
Crossref
Bogdan Prokopczyk, José G Rosa, Dhimant Desai, Shantu Amin, Ock Soon Sohn, Emerich S Fiala & Karam El-Bayoumy. (2000) Chemoprevention of lung tumorigenesis induced by a mixture of benzo( a )pyrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by the organoselenium compound 1,4-phenylenebis(methylene)selenocyanate. Cancer Letters 161:1, pages 35-46.
Crossref
B Coles. (2000) Expression of hGSTP1 alleles in human lung and catalytic activity of the native protein variants towards 1-chloro-2,4-dinitrobenzene, 4-vinylpyridine and (+)-anti benzo[a]pyrene-7,8-diol-9,10-oxide. Cancer Letters 156:2, pages 167-175.
Crossref
F.F. Shadan & J. Koziol. (2000) Induced genome instability as a potential screening test for cancer susceptibility?. Medical Hypotheses 55:1, pages 69-72.
Crossref
Gayatri Ramakrishna, Aneta Bialkowska, Christine Perella, Lisa Birely, Laura W. Fornwald, Bhalchandra A. Diwan, Yih-Horng Shiao & Lucy M. Anderson. (2000) Ki-ras and the Characteristics of Mouse Lung Tumors. Molecular Carcinogenesis 28:3, pages 156-167.
Crossref
Robert A. Smith & Thomas J. Glynn. (2000) EPIDEMIOLOGY OF LUNG CANCER. Radiologic Clinics of North America 38:3, pages 453-470.
Crossref
F. P. Perera. (2000) Molecular Epidemiology: On the Path to Prevention?. JNCI Journal of the National Cancer Institute 92:8, pages 602-612.
Crossref
WILLIAM N. ROM, JOHN G. HAY, THEODORE C. LEE, YIXING JIANG & KAM-MENG TCHOU-WONG. (2000) Molecular and Genetic Aspects of Lung Cancer. American Journal of Respiratory and Critical Care Medicine 161:4, pages 1355-1367.
Crossref
A.-K. Alexandrie, M. Warholm, U. Carstensen, A. Axmon, L. Hagmar, J. O. Levin, C. Ostman & A. Rannug. (2000) CYP1A1 and GSTM1 polymorphisms affect urinary 1-hydroxypyrene levels after PAH exposure. Carcinogenesis 21:4, pages 669-676.
Crossref
Christopher D. Simpson, Ming-Tsang Wu, David C. Christiani, Regina M. Santella, Steven G. Carmella & Stephen S. Hecht. (2000) Determination of r -7, t -8,9, c -10-Tetrahydroxy-7,8,9,10-tetrahydrobenzo[ a ]pyrene in Human Urine by Gas Chromatography/Negative Ion Chemical Ionization/Mass Spectrometry . Chemical Research in Toxicology 13:4, pages 271-280.
Crossref
Miriam C. Poirier, Regina M. Santella & Ainsley Weston. (2000) Carcinogen macromolecular adducts and their measurement. Carcinogenesis 21:3, pages 353-359.
Crossref
S. P. Shriver, H. A. Bourdeau, C. T. Gubish, D. L. Tirpak, A. L. G. Davis, J. D. Luketich & J. M. Siegfried. (2000) Sex-Specific Expression of Gastrin-Releasing Peptide Receptor: Relationship to Smoking History and Risk of Lung Cancer. JNCI Journal of the National Cancer Institute 92:1, pages 24-33.
Crossref
Suryanarayana V. Vulimiri, Xifeng Wu, Wanda Baer-Dubowska, Mariza de Andrade, Michelle Detry, Margaret R. Spitz & John DiGiovanni. (2000) Analysis of aromatic DNA adducts and 7,8-dihydro-8-oxo- 2′-deoxyguanosine in lymphocyte DNA from a case–control study of lung cancer involving minority populations. Molecular Carcinogenesis 27:1, pages 34-46.
Crossref
Jamie Ostroff, Jennifer Hay, Louis Primavera, Patrick Bivona, Gustavo Cruz & Racquel LeGeros. (1999) Motivating smoking cessation among dental patients: Smokers' interest in biomarker testing for susceptibility to tobacco-related cancers. Nicotine & Tobacco Research 1:4, pages 347-355.
Crossref
Kwun M. Fong, Yoshitaka Sekido & John D. Minna. (1999) Molecular pathogenesis of lung cancer. The Journal of Thoracic and Cardiovascular Surgery 118:6, pages 1136-1152.
Crossref
Jill M. Siegfried. (1999) Lung Cancer Screening in High-Risk Populations. Clinical Lung Cancer 1:2, pages 100-106.
Crossref
S. S. Hecht. (1999) Tobacco Smoke Carcinogens and Lung Cancer. JNCI Journal of the National Cancer Institute 91:14, pages 1194-1210.
Crossref
Simon D. Spivack & Eugene J. Mark. (1999) Case 21-1999. New England Journal of Medicine 341:3, pages 182-190.
Crossref
J. Cloos, E. J. C. Nieuwenhuis, D. I. Boomsma, D. J. Kuik, M. L. T. van der Sterre, F. Arwert, G. B. Snow & B. J. M. Braakhuis. (1999) Inherited Susceptibility to Bleomycin-Induced Chromatid Breaks in Cultured Peripheral Blood Lymphocytes. JNCI Journal of the National Cancer Institute 91:13, pages 1125-1130.
Crossref
James P. WhitlockJr.Jr.. (1999) INDUCTION OF CYTOCHROME P4501A1. Annual Review of Pharmacology and Toxicology 39:1, pages 103-125.
Crossref
E. Jassem & J. Jassem. 1998. Molecular Aspects of Cancer and its Therapy. Molecular Aspects of Cancer and its Therapy 45 57 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.